Startup Story: Kyntox Biotech, Revolutionizing the healthcare through passive immunotherapy
We are a growing company trying to overcome the hurdles in healthcare industry. We believe that with our expertise on IgY antibody technology, we can definitely improve the quality of life and save many more lives from diseases caused by various microbials. Our unique approach and knowledge base enable the creation of immune health solutions that address a range of needs related to the health of humans and animals. Antimicrobials Many therapeutic approaches are available to address the pathogens which includes, probiotics, antibiotics, bacteriophages and others, but safety and antibiotic resistance is the major concern. To address these limitations, Kyntox Biotech is using avian (IgY) antibody technology that is safe and effective against specific and narrow targeted bacteria/ fungi/viruses. Being polyclonal, our technology prevents the generation of resistance to therapy, unlike any antibiotics/small molecules for long term dosing. IgY based Therapeutics: For selective removal o...